Neuralstem, Inc. (NASDAQ:CUR)
Neuralstem, Inc. (NASDAQ:CUR) represented a move of 0 percent or $0.01 per share and closed its previous day trading session at $0.47. 0 Shares were traded in the last trading session with an Average Volume of 175.02 Million Shares. The stock currently has a Market Capitalization of 8.81 Million.
NEURALSTEM’s patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug application will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment.
The stock traded between $0.470 and $3.090 over 1-Year time period showing its price to sales ratio of 17.62. Neuralstem, Inc. (NASDAQ:CUR) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-37.96 and 200-Day Simple Moving Average of $-63.16. Its Price to Free Cash Flow is 0 and Price to Book of 1.61.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Neuralstem, Inc. (NASDAQ:CUR) reported its Actual EPS of $-0.36/share. The analysts offering Earnings Estimates for the company were believing that Neuralstem, Inc. could bring EPS of $-0.73/share. The difference between Actual EPS and Estimated EPS was 0.37 Percent. Thus showing an Earnings Surprise of 50.7 Percent.
CHF Solutions, Inc. (NASDAQ:CHFS)
In the last trading session, CHF Solutions, Inc. (NASDAQ:CHFS) added its value by 0% closing at the price of $0.84. The stock currently has market capitalization of 5.89 Million, with average volume of 154.51 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently CHF Solutions, Inc. (NASDAQ:CHFS) is showing beta of 2.25. This particular value of beta suggests that CHF Solutions, Inc. (NASDAQ:CHFS) has historically moved 225% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for CHF Solutions, Inc. (NASDAQ:CHFS) is at $-14.45.
The stock currently has RSI of 36.29. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
CHF Solutions, Inc. is a medical device company which focused on commercializing the Aquadex FlexFlow (R) System. Its commercial product Aquadex system, is indicated for temporary ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and extended ultrafiltration treatment of patients with fluid overload who have failed diuretic therapy and require hospitalization. CHF Solutions Inc., formerly known as Sunshine Heart Inc., is headquartered in Minneapolis.
CHF Solutions, Inc. (NASDAQ:CHFS) topped its 52-week high price of $4.800 on 01/29/18 and 52-Week Low Price of $0.770 on 10/29/18. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 10.18% and monthly volatility of 11.12% respectively.